2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 9.297 | 48.166 | 50.894 | 76.873 | 61.000 | 24.023 | 61.674 | 43.543 | 58.218 |
Total Income - EUR | - | 11.273 | 55.374 | 57.531 | 83.304 | 65.204 | 28.147 | 65.707 | 88.337 | 58.219 |
Total Expenses - EUR | - | 35.986 | 37.223 | 37.255 | 63.644 | 45.520 | 25.858 | 22.518 | 20.284 | 18.637 |
Gross Profit/Loss - EUR | - | -24.712 | 18.151 | 20.276 | 19.660 | 19.684 | 2.289 | 43.189 | 68.053 | 39.582 |
Net Profit/Loss - EUR | - | -24.991 | 17.670 | 18.321 | 18.891 | 19.074 | 2.136 | 42.615 | 67.618 | 39.070 |
Employees | - | 3 | 4 | 4 | 4 | 4 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Arhimede Medical Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 102.709 | 86.491 | 70.114 | 54.889 | 40.157 | 25.985 | 12.705 | 0 | 0 |
Current Assets | - | 91.054 | 37.227 | 56.411 | 110.295 | 123.254 | 127.333 | 171.151 | 114.188 | 81.677 |
Inventories | - | 0 | 26 | 77 | 0 | 71 | 70 | 980 | 983 | 819 |
Receivables | - | 89.589 | 4.170 | 2.439 | 5.277 | 40.104 | 37.837 | 63.819 | 64.021 | 73.301 |
Cash | - | 1.464 | 33.032 | 53.896 | 105.018 | 83.079 | 89.426 | 106.352 | 49.184 | 7.558 |
Shareholders Funds | - | -37.444 | 21.831 | 39.783 | 57.944 | 75.896 | 76.593 | 117.442 | 95.975 | 78.832 |
Social Capital | - | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | 59.534 | 101.986 | 20.888 | 49.119 | 34.724 | 29.059 | 23.838 | 20.296 | 4.922 |
Income in Advance | - | 171.773 | 73.619 | 68.007 | 60.329 | 54.957 | 49.791 | 44.654 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8623 - 8623" | |||||||||
CAEN Financial Year |
8623
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Arhimede Medical Srl